BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 62 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q1 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $60,000 | -52.4% | 243,805 | 0.0% | 0.00% | – |
| Q2 2022 | $126,000 | -86.6% | 243,805 | -47.0% | 0.00% | – |
| Q1 2022 | $943,000 | -51.8% | 460,119 | -1.9% | 0.00% | – |
| Q4 2021 | $1,955,000 | -51.2% | 468,871 | +8.9% | 0.00% | -100.0% |
| Q3 2021 | $4,005,000 | -37.8% | 430,670 | +20.4% | 0.00% | 0.0% |
| Q2 2021 | $6,443,000 | +16420.5% | 357,756 | +3278.6% | 0.00% | – |
| Q1 2021 | $39,000 | – | 10,589 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJ WEALTH STRATEGIES, LLC | 36,001 | $0 | 0.00% |